ConvaTec Group PLC (LON:CTEC - Get Free Report)'s stock price shot up 2.3% during mid-day trading on Friday . The stock traded as high as GBX 236 ($2.96) and last traded at GBX 235.80 ($2.96). 5,676,515 shares changed hands during mid-day trading, a decline of 18% from the average session volume of 6,914,979 shares. The stock had previously closed at GBX 230.60 ($2.89).
Analyst Ratings Changes
A number of equities analysts have recently weighed in on CTEC shares. Royal Bank of Canada cut their price objective on shares of ConvaTec Group from GBX 320 ($4.01) to GBX 305 ($3.82) and set an "outperform" rating for the company in a research report on Wednesday, July 31st. JPMorgan Chase & Co. lowered their target price on shares of ConvaTec Group from GBX 323 ($4.05) to GBX 290 ($3.64) and set an "overweight" rating for the company in a research note on Wednesday, July 31st. Finally, Berenberg Bank reissued a "buy" rating and set a GBX 310 ($3.89) price target on shares of ConvaTec Group in a research note on Tuesday, August 6th.
Get Our Latest Stock Analysis on ConvaTec Group
ConvaTec Group Price Performance
The stock has a market cap of £4.83 billion, a PE ratio of 3,930.00, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64. The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32. The company's fifty day moving average is GBX 226.67 and its 200 day moving average is GBX 237.50.
About ConvaTec Group
(
Get Free Report)
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
See Also
Before you consider ConvaTec Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ConvaTec Group wasn't on the list.
While ConvaTec Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
